Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Control Groups × Gastrointestinal × Clear all

Phase

Phase NA 21 Phase 4 4 Phase 3 4 Phase 2 2 Phase EARLY_PHASE1 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 9 Gemcitabine 6 Biopsy 6 Bevacizumab 6 pembrolizumab 5 Specimen Handling 5 Oxaliplatin 5 Fluorouracil 5 Radiosurgery 4 Nivolumab 4 Leucovorin 4 Irinotecan 4 Cyclophosphamide 4 Cisplatin 4 Capecitabine 4 Albumin-Bound Paclitaxel 4 130-nm albumin-bound paclitaxel 4 sodium thiosulfate 3 lenvatinib 3 folfirinox 3 X-Rays 3 Paclitaxel 3 Ketamine 3 Folfox protocol 3 Fluorodeoxyglucose F18 3 Doxorubicin 3 Cholecalciferol 3 Cetuximab 3 tislelizumab 2 paricalcitol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02304978 2025-12-26

TF

University Hospital, Lille

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡